Sam Salman is the Co-Founder and Managing Director of MiRNA Scientific, Inc., a position held since 2024. They previously served as President at Errant Gene Therapeutics, LLC from 2009 to 2020, leading innovations in gene therapy for blood disorders and cancers. Sam has also held senior roles, including President at Boymelgreen Holdings and LiberyPointe Capital, and Chairman & CEO at NRS Associates, LLC since 2006. Additionally, they contributed to impactful organizations, serving on the Board of Trustees for Multiplying Good since 2012 and guiding Mission Markets as President and CEO from 2011 to 2012.
This person is not in the org chart
This person is not in any teams
This person is not in any offices